Literature DB >> 22978742

Animal models in virus research: their utility and limitations.

Derrick Louz1, Hans E Bergmans, Birgit P Loos, Rob C Hoeben.   

Abstract

Viral diseases are important threats to public health worldwide. With the number of emerging viral diseases increasing the last decades, there is a growing need for appropriate animal models for virus studies. The relevance of animal models can be limited in terms of mimicking human pathophysiology. In this review, we discuss the utility of animal models for studies of influenza A viruses, HIV and SARS-CoV in light of viral emergence, assessment of infection and transmission risks, and regulatory decision making. We address their relevance and limitations. The susceptibility, immune responses, pathogenesis, and pharmacokinetics may differ between the various animal models. These complexities may thwart translating results from animal experiments to the humans. Within these constraints, animal models are very informative for studying virus immunopathology and transmission modes and for translation of virus research into clinical benefit. Insight in the limitations of the various models may facilitate further improvements of the models.

Entities:  

Mesh:

Year:  2012        PMID: 22978742     DOI: 10.3109/1040841X.2012.711740

Source DB:  PubMed          Journal:  Crit Rev Microbiol        ISSN: 1040-841X            Impact factor:   7.624


  9 in total

Review 1.  Three-dimensional cell culture models for investigating human viruses.

Authors:  Bing He; Guomin Chen; Yi Zeng
Journal:  Virol Sin       Date:  2016-10-27       Impact factor: 4.327

2.  Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding.

Authors:  Tyler N Starr; Allison J Greaney; Sarah K Hilton; Katharine H D Crawford; Mary Jane Navarro; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; David Veesler; Jesse D Bloom
Journal:  bioRxiv       Date:  2020-06-17

3.  Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding.

Authors:  Tyler N Starr; Allison J Greaney; Sarah K Hilton; Daniel Ellis; Katharine H D Crawford; Adam S Dingens; Mary Jane Navarro; John E Bowen; M Alejandra Tortorici; Alexandra C Walls; Neil P King; David Veesler; Jesse D Bloom
Journal:  Cell       Date:  2020-08-11       Impact factor: 41.582

4.  A Perspective on Organoids for Virology Research.

Authors:  Adithya Sridhar; Salvatore Simmini; Carla M S Ribeiro; Caroline Tapparel; Melvin M Evers; Dasja Pajkrt; Katja Wolthers
Journal:  Viruses       Date:  2020-11-23       Impact factor: 5.048

Review 5.  Physiologically relevant microsystems to study viral infection in the human liver.

Authors:  Dennis McDuffie; David Barr; Ashutosh Agarwal; Emmanuel Thomas
Journal:  Front Microbiol       Date:  2022-09-28       Impact factor: 6.064

Review 6.  3D Cell Culture Models in COVID-19 Times: A Review of 3D Technologies to Understand and Accelerate Therapeutic Drug Discovery.

Authors:  Guadalupe Tonantzin de Dios-Figueroa; Janette Del Rocío Aguilera-Marquez; Tanya A Camacho-Villegas; Pavel H Lugo-Fabres
Journal:  Biomedicines       Date:  2021-05-26

7.  High dose sertraline monotherapy fails to protect rhesus macaques from lethal challenge with Ebola virus Makona.

Authors:  Anna N Honko; Joshua C Johnson; Jonathan S Marchand; Louis Huzella; Ricky D Adams; Nicholas Oberlander; Lisa M Torzewski; Richard S Bennett; Lisa E Hensley; Peter B Jahrling; Gene G Olinger
Journal:  Sci Rep       Date:  2017-07-19       Impact factor: 4.379

Review 8.  Discovery and development of safe-in-man broad-spectrum antiviral agents.

Authors:  Petter I Andersen; Aleksandr Ianevski; Hilde Lysvand; Astra Vitkauskiene; Valentyn Oksenych; Magnar Bjørås; Kaidi Telling; Irja Lutsar; Uga Dumpis; Yasuhiko Irie; Tanel Tenson; Anu Kantele; Denis E Kainov
Journal:  Int J Infect Dis       Date:  2020-02-17       Impact factor: 3.623

Review 9.  Targeting the DEAD-Box RNA Helicase eIF4A with Rocaglates-A Pan-Antiviral Strategy for Minimizing the Impact of Future RNA Virus Pandemics.

Authors:  Gaspar Taroncher-Oldenburg; Christin Müller; Wiebke Obermann; John Ziebuhr; Roland K Hartmann; Arnold Grünweller
Journal:  Microorganisms       Date:  2021-03-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.